世界の生物学的安全性試験市場(製品タイプ-機器、試薬、キット;試験-エンドトキシン試験、無菌試験、細胞株認証、特性試験、バイオバーデン試験、残存宿主汚染物質検出試験、不定期薬剤検出試験、毒性試験、安定性試験;用途-ワクチン、治療薬、血液、血液製剤、組織、組織製品、幹細胞製品、遺伝子治療、細胞療法)-グローバル産業分析、規模、シェア、成長、動向及び予測2016-2024

◆英語タイトル:Biological Safety Testing Market (Product Type - Instruments and Reagents & Kits; Test - Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests; Application - Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
◆商品コード:TMR706121
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2017年4月6日
◆ページ数:181
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥643,245見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥976,245見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,309,245見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界の生物学的安全性試験市場について調査・分析し、産業分析、世界の生物学的安全性試験市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・世界の生物学的安全性試験市場:序文
・世界の生物学的安全性試験市場:エグゼクティブサマリー
・世界の生物学的安全性試験市場:市場概要・動向
・世界の生物学的安全性試験市場:セグメント別市場規模・分析
・世界の生物学的安全性試験市場:地域別市場規模・分析
・世界の生物学的安全性試験市場:関連企業分析
【レポートの概要】

Global Biological Safety Testing Market: Overview

This report on biological safety testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various biological safety testing instrument and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global biological safety testing market with respect to the leading market segments based on major products, applications and geographies.

Global Biological Safety Testing Market: Key Segments

The global biological safety testing market is divided into: by product, by test type, by application and by geography. Product type segment of tissue market was divided into instruments and reagents & kits. On the basis of test type the biological safety testing market is classified as Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Other Tests (Toxicity tests, Stability tests, etc.). On the basis of application the biological safety testing market is classified as Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy. Vaccines & Therapeutics and Blood & Blood Products.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2016 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2016 as the base year.

Global Biological Safety Testing Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global biological safety testing market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/technologies/end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Biological Safety Testing Market: Regional Outlook

Geographically, the biological safety testing market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for biological safety testing market has been further categorized into major product, applications, material, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2014 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Companies Mentioned in the Report

The report profiles key manufacturers in the biological safety testing market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Merck KGaA, Lonza Group, Avance Biosciences, SGS SA, WuXi PharmaTech (Cayman) Inc., Toxikon, Inc., Nordic Scientific & Natural Solutions AB, Paragon Bioservices, Inc., and NuAire.

The global Biological safety testing market has been segmented as follows:

Biological safety testing Market, by Product Type

Instruments
Biological Safety Cabinet (class I, class II, class III)
Autoclaves
Laboratory Centrifuges
Others
Reagent & Kits
Biological safety testing Market, by Test Type

Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Other Tests (Toxicity tests, Stability tests, etc.)
Biological safety testing Market, By Application

Vaccines & Therapeutics
Blood & Blood Products
Tissue & Tissue Products
Stem Cell Products
Gene Therapy
Cellular Therapy
Biological safety testing Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
Spain
Italy
U.K.
Rest of Europe
Asia Pacific
Japan
China
India
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
Saudi Arabia
South Africa
Rest of MEA

【レポートの目次】

Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section-2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Biological Safety Testing Market: Market Snapshot
3.2 Global Biological Safety Testing Market: Opportunity Map

Section-4 Market Overview
4.1 Global Biological Safety Testing Market: Product Overview
4.2 Global Biological Safety Testing Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.1 Drivers
5.1.1.1 Growing biopharmaceutical industry
5.1.1.2 Increasing prevalence of chronic diseases
5.1.1.3 Improving health care infrastructure
5.1.1.4 Technological advancements
5.1.1.5 Increasing government initiatives
5.1.1.6 Rising drug development
5.1.2 Restraints
5.1.2.1 High health care cost
5.1.2.2 Regulatory scenario
5.1.2.3 Lack of trained professionals
5.1.3 Opportunity
5.1.3.1 Technological development and innovation
5.1.3.2 Expansion in emerging economies such as countries in Asia Pacific, South Africa, and Brazil
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Biological Safety Testing Market Revenue Forecast
5.5 Porter’s Five Forces Analysis
5.6 Global Biological Safety Testing Market Outlook

Section-6 Global Biological Safety Testing Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 Global Biological Safety Testing Market Value Share Analysis, by Product Type
6.4 Global Biological Safety Testing Market Forecast, by Product Type
6.4.1 Instruments
6.4.2 Reagents & Kits
6.5 Global Biological Safety Testing Market Attractiveness Analysis

Section-7 Biological Safety Testing Market Analysis, by Test Type
7.1 Key Findings
7.2 Introduction
7.3 Global Biological Safety Testing Market Value Share Analysis, by Test Type
7.4 Global Biological Safety Testing Market Forecast, by Test Type
7.4.1 Endotoxin Tests
7.4.2 Sterility Tests
7.4.3 Cell Line Authentication and Characterization Tests
7.4.4 Bioburden Tests
7.4.5 Residual Host Contaminant Detection Tests
7.4.6 Adventitious Agent Detection Tests
7.4.7 Other Tests (Toxicity tests, Stability tests, etc.)

Section-8 Biological Safety Testing Market Analysis, by Test Type
8.1 Key Findings
8.2 Introduction
8.3 Global Biological Safety Testing Market Value Share Analysis, by Application Type
8.4 Global Biological Safety Testing Market Forecast, by Application Type
8.4.1 Vaccines and Therapeutics
8.4.2 Blood and Blood Products
8.4.3 Cellular Therapy
8.4.4 Gene Therapy
8.4.5 Tissue and Tissue Products
8.4.6 Stem Cell Products
8.4.7 Others

Section-9 North America Biological Safety Testing Market Analysis
9.1 North America Market Overview
9.2 North America Market Value Share Analysis, By Product Type
9.2.1 North America Market Forecast By Product Type
9.3 North America Market Value Share Analysis, By Test
9.3.1 North America Market Forecast By Test
9.4 North America Market Value Share Analysis, By Application
9.4.1 North America Market Forecast By Application
9.5 North America Market Value Share Analysis, By Country
9.5.1 North America Market Value Share Analysis Forecast, by Country
9.6 Key Trends

Section-10 Europe Biological Safety Testing Market Analysis
10.1 Europe Market Overview
10.2 Europe Market Value Share Analysis, By Product Type
10.2.1 Europe Market Forecast by Product Type
10.3 Europe Market Value Share Analysis, By Test
10.3.1 Europe Market Forecast by Test
10.4 Europe Market Value Share Analysis, By Application
10.4.1 Europe Market Forecast by Application
10.5 Europe Market Value Share Analysis, By Country
10.5.1 Europe Market Value Share Analysis Forecast, by Country
10.6 Key Trends

Section-11 Asia Pacific Biological Safety Testing Market Analysis
11.1 Asia Pacific Market Overview
11.2 Asia Pacific Market Value Share Analysis, By Product Type
11.2.1 Asia Pacific Market Forecast by Product Type
11.3 Asia Pacific Market Value Share Analysis, By Test
11.3.1 Asia Pacific Market Forecast by Test
11.4 Asia Pacific Market Value Share Analysis, By Application
11.4.1 Asia Pacific Market Forecast by Application
11.5 Asia Pacific Market Value Share Analysis, By Country
11.5.1 Asia Pacific Market Value Share Analysis Forecast, by Country
11.6 Key Trends

Section-12 Latin America Biological Safety Testing Market Analysis
12.1 Latin America Market Overview
12.2 Latin America Market Value Share Analysis, By Product Type
12.2.1 Latin America Market Forecast by Product Type
12.3 Latin America Market Value Share Analysis, By Test
12.3.1 Latin America Market Forecast by Test
12.4 Latin America Market Value Share Analysis, By Application
12.4.1 Latin America Market Forecast by Application
12.5 Latin America Market Value Share Analysis, By Country
12.5.1 Latin America Market Value Share Analysis Forecast, by Country
12.6 Key Trends

Section-13 Middle East & Africa Biological Safety Testing Market Analysis
13.1 Middle East & Africa Market Overview
13.2 Middle East & Africa Market Value Share Analysis, By Product Type
13.2.1 Middle East & Africa Market Forecast by Product Type
13.3 Middle East & Africa Market Value Share Analysis, By Test
13.3.1 Middle East & Africa Market Forecast by Test
13.4 Middle East & Africa Market Value Share Analysis, By Application
13.4.1 Middle East & Africa Market Forecast by Application
13.5 Middle East & Africa Market Value Share Analysis, By Country
13.5.1 Middle East & Africa Market Value Share Analysis Forecast, by Country
13.6 Key Trends

Section-14 Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. Avance Biosciences
14.2.1.1 Company Overview
14.2.1.2 Business Overview
14.2.1.3 Financial Overview
14.2.1.4 SWOT Analysis
14.2.1.5 Strategic Overview
14.2.2 Charles River Laboratories
14.2.2.1 Company Overview
14.2.2.2 Business Overview
14.2.2.3 Financial Overview
14.2.2.4 SWOT Analysis
14.2.2.5 Strategic Overview
14.2.3 Lonza Group
14.2.3.1 Company Overview
14.2.3.2 Business Overview
14.2.3.3 Financial Overview
14.2.3.4 SWOT Analysis
14.2.3.5 Strategic Overview
14.2.4 Merck KGaA
14.2.4.1 Company Overview
14.2.4.2 Business Overview
14.2.4.3 Financial Overview
14.2.4.4 SWOT Analysis
14.2.4.5 Strategic Overview
14.2.5 Nordic Scientific & Natural Solutions AB.
14.2.5.1 Company Overview
14.2.5.2 Business Overview
14.2.5.3 Financial Overview
14.2.5.4 SWOT Analysis
14.2.5.5 Strategic Overview
14.2.6 NuAire
14.2.6.1 Company Overview
14.2.6.2 Business Overview
14.2.6.3 Financial Overview
14.2.6.4 SWOT Analysis
14.2.6.5 Strategic Overview
14.2.7 Paragon Bioservices, Inc.
14.2.7.1 Company Overview
14.2.7.2 Business Overview
14.2.7.3 Financial Overview
14.2.7.4 SWOT Analysis
14.2.7.5 Strategic Overview
14.2.8 SGS S.A.
14.2.8.1 Company Overview
14.2.8.2 Business Overview
14.2.8.3 Financial Overview
14.2.8.4 SWOT Analysis
14.2.8.5 Strategic Overview
14.2.9 Thermo Fisher Scientific Inc.
14.2.9.1 Company Overview
14.2.9.2 Business Overview
14.2.9.3 Financial Overview
14.2.9.4 SWOT Analysis
14.2.9.5 Strategic Overview
14.2.10. Toxicon Corporation
14.2.10.1 Company Overview
14.2.10.2 Business Overview
14.2.10.3 Financial Overview
14.2.10.4 SWOT Analysis
14.2.10.5 Strategic Overview
14.2.11. Wuxi Pharmatech (Cayman) Inc.
14.2.11.1 Company Overview
14.2.11.2 Business Overview
14.2.11.3 Financial Overview
14.2.11.4 SWOT Analysis
14.2.11.5 Strategic Overview

List of Figures

Figure 1: Global Biological Safety Testing Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 3: Global Instruments Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014– 2024
Figure 4: Global Reagents & Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: Biological Safety Testing Market Attractiveness Analysis,
Figure 6: Global Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 7: Global Endotoxin Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 8: Global Sterility Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014– 2024
Figure 9: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Bioburden Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Residual Host Contaminant Detection Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Adventitious Agent Detection Tests Market Revenue (US$ Mn) and Y- o-Y Growth (%), 2014–2024
Figure 13: Global Other Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014– 2024
Figure 14: Biological Safety Testing Market Attractiveness Analysis, by Test Type
Figure 15: Global Biological Safety Testing Market Value Share Analysis, by Technology, 2016 and 2024
Figure 16: Global Vaccines & Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 17: Global Blood & Blood Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 18: Global Tissue & Tissue Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 19: Global Stem Cell Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014– 2024
Figure 20: Global Gene Therapy Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 21: Global Cellular Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 22: Biological Safety Testing Market Attractiveness Analysis, by Application
Figure 23: Global Biological Safety Testing Market Value Share Analysis, by Region, 2016 and 2024
Figure 24: Biological Safety Testing Market Attractiveness Analysis, by Region
Figure 25: North America Biological Safety Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 26: North America Biological Safety Testing Market Size, 2015–2024
Figure 27: North America Biological Safety Testing Market Attractiveness Analysis, by Country
Figure 28: North America Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 29: Biological Safety Testing Market Attractiveness Analysis, by Product Type
Figure 30: North America Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 31: Biological Safety Testing Market Attractiveness Analysis, by Test Type
Figure 32: North America Biological Safety Testing Market Value Share Analysis, by Application, 2016 and 2024
Figure 33: Biological Safety Testing Market Attractiveness Analysis, by Application
Figure 34: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 35: Europe Biological Safety Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 36: Europe Biological Safety Testing Market Size, 2015–2024
Figure 37: Europe Biological Safety Testing Market Attractiveness Analysis, by Country
Figure 38: Europe Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 39: Biological Safety Testing Market Attractiveness Analysis, by Product Type
Figure 40: Europe Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 41: Biological Safety Testing Market Attractiveness Analysis, by Test Type
Figure 42: Europe Biological Safety Testing Market Value Share Analysis, by Application, 2016 and 2024
Figure 43: Biological Safety Testing Market Attractiveness Analysis, by Application
Figure 44: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 45: Asia Pacific Biological Safety Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 46: Asia Pacific Biological Safety Testing Market Size, 2015–2024
Figure 47: Asia Pacific Biological Safety Testing Market Attractiveness Analysis, by Country
Figure 48: Asia Pacific Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 49: Biological Safety Testing Market Attractiveness Analysis, by Product Type
Figure 50: Asia Pacific Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 51: Biological Safety Testing Market Attractiveness Analysis, by Test Type
Figure 52: Asia Pacific Biological Safety Testing Market Value Share Analysis, by Application, 2016 and 2024
Figure 53: Biological Safety Testing Market Attractiveness Analysis, by Application
Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 55: Latin America Biological Safety Testing Market Size (US$ Mn) Forecast,
Figure 56: Latin America Biological Safety Testing Market Y-o-Y Growth (%) Projection, 2015– 2024
Figure 57: Latin America Biological Safety Testing Market Attractiveness Analysis, by Country
Figure 58: Latin America Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 59: Latin America Biological Safety Testing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 60: Latin America Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 61: Latin America Biological Safety Testing Market Attractiveness Analysis, by Test Type, 2016–2024
Figure 62: Latin America Biological Safety Testing Market Value Share Analysis, by Application Type, 2016 and 2024
Figure 63: Latin America Biological Safety Testing Market Attractiveness Analysis, by Application Type, 2016–2024
Figure 64: Latin America Biological Safety Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 65: Middle East & Africa Biological Safety Testing Market Size (US$ Mn) Forecast, 2016– 2024
Figure 66: Middle East & Africa Biological Safety Testing Market Size, 2015–2024
Figure 67: Middle East & Africa Biological Safety Testing Market Attractiveness Analysis, by Country
Figure 68: Middle East & Africa Biological Safety Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 69: Biological Safety Testing Market Attractiveness Analysis, by Product Type
Figure 70: Middle East & Africa Biological Safety Testing Market Value Share Analysis, by Test Type, 2016 and 2024
Figure 71: Biological Safety Testing Market Attractiveness Analysis, by Test Type
Figure 72: Middle East & Africa Biological Safety Testing Market Value Share Analysis, by Application, 2016 and 2024
Figure 73: Biological Safety Testing Market Attractiveness Analysis, by Application
Figure 74: Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2024
Figure 75: Global Biological Safety Testing Market Share Analysis, by Company (2015)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の生物学的安全性試験市場(製品タイプ-機器、試薬、キット;試験-エンドトキシン試験、無菌試験、細胞株認証、特性試験、バイオバーデン試験、残存宿主汚染物質検出試験、不定期薬剤検出試験、毒性試験、安定性試験;用途-ワクチン、治療薬、血液、血液製剤、組織、組織製品、幹細胞製品、遺伝子治療、細胞療法)-グローバル産業分析、規模、シェア、成長、動向及び予測2016-2024(Biological Safety Testing Market (Product Type - Instruments and Reagents & Kits; Test - Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests; Application - Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆